固体器官移植后脆弱性变化的系统审查:这一切都是关于脆弱性的工具吗?
Kaixin Li1, Trent Payne1, Ross Francis2
1Centre for Health Services Research, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Australia.
Transplantation reviews (Orlando, Fla.)
|November 17, 2025
概括
脆弱性评估工具的选择显著影响了固体器官移植 (SOT) 后的结果. 现型工具始终显示SOT后的脆弱性改善,而不是产生可变结果的赤字积累工具.
科学领域:
- 老年学是指老年学的学科.
- 移植医学 移植医学
- 临床评估 临床评估
背景情况:
- 脆弱性是患有晚期器官疾病 (AOD) 的患者日益关注的问题.
- 固体器官移植 (SOT) 改善了AOD患者的生存率,但对脆弱性有不同的影响.
- 现有的文献显示,SOT后的脆弱状态发生了不一致的变化.
研究的目的:
- 调查不同类型的脆弱性评估工具对SOT后报告结果的影响.
- 确定工具选择是否有助于移植后脆弱性变化的异质性.
主要方法:
- 在主要数据库 (PubMed,Embase等) 的系统文献搜索. 在2025年8月之前.
- 将脆弱工具分为表型和缺陷积累类型的分类.
- 根据工具和器官类型对流行数据和子组分析进行元分析;对得分变化和转变进行叙事综合.
主要成果:
- 现型工具在SOT后的中间阶段 (6-12个月) 始终显示虚弱率降低.
- 逆差累积工具产生了不一致的结果,具有很高的异质性.
- 测量物理领域的表型工具更常见;一些缺陷工具表明恶化.
结论:
- 现型脆弱工具可靠地表明在SOT后的中间恢复期间的改善.
- 缺陷积累工具提供了可变的发现,强调了工具选择在评估SOT后脆弱性的关键作用.
相关概念视频
Kidney Transplant I: Introduction
312
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
312
Kidney Transplant III: Nursing Management
298
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
298
Heart Failure VI: Adjunct Therapies
239
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
239
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
217
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
217
Tissue Transplantation
875
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
875
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180


